Indian Council of Medical Research (ICMR) showed in a recent study that a combination of Covaxin and Covishield used to vaccinate a set of 18 people showed better and stronger immune response. Better safety and immunogenicity results came up in this particular study.
Administering people a dose of Covishield, followed by Covaxin in the second dose is safe and improves immunity, according to a study by the Indian Council of Medical Research (ICMR) released on Sunday. Covishield, developed by University of Oxford-Astrazeneca, is a viral vector vaccine that uses an adenovirus found in Chimpanzees, to deliver spike proteins and mount a tolerable immune response in response to a live virus, Covaxin, developed by the Hyderabad-based Bharat Biotech uses a similar inactive viral strain.
The Indian Council of Medical Research (ICMR) has invited call for Letters of Intent on venous thromboembolism (VTE).